News Releases Keyword search Year All20242023202220212020201920182017201620152014201320122011201020092008 11/13/2024 Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update 11/6/2024 Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024 10/8/2024 Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit 9/5/2024 Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 8/19/2024 Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit 8/14/2024 Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update 8/5/2024 Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024 5/20/2024 Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 5/16/2024 Talphera to Participate at A.G.P. Virtual Healthcare Conference 5/14/2024 Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update Overview News & Events News Releases Upcoming Events Past Events Stock Information Stock Quote & Chart Price Lookup Investment Calculator IRS Form 8937 Analyst Coverage SEC Filings Corporate Governance Highlights Senior Management Board of Directors Shareholder Services Information Request Email Alerts Print Page RSS Feeds
Keyword search Year All20242023202220212020201920182017201620152014201320122011201020092008 11/13/2024 Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update 11/6/2024 Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024 10/8/2024 Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit 9/5/2024 Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 8/19/2024 Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit 8/14/2024 Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update 8/5/2024 Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024 5/20/2024 Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 5/16/2024 Talphera to Participate at A.G.P. Virtual Healthcare Conference 5/14/2024 Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update
11/6/2024 Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024
8/19/2024 Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit
8/5/2024 Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024
